June 07, 2017 | Larry Roberts
Department of Anesthesiology
(410) 328-6120 (phone)
(410) 328-5531 (fax)
University of Maryland School of Medicine
Tuesday, May 10, 2022
Longtime Academic and Clinical Affairs Leader, Department Chair, and Faculty Member, Tony Lehman, MD, Announces Retirement
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that Anthony Lehman, MD, MSPH, who served the UMSOM for more than 30 years as Senior Associate Dean for Clinical Affairs, Department Chair, and distinguished faculty member in the UMSOM Department of Psychiatry, will retire, effective June 30, 2022.
Thursday, September 23, 2021
Dr. Deanna Kelly Appointed New Chair of Institutional Review Board for the Maryland Department of Health
Deanna Kelly, PharmD, Professor of Psychiatry at the University of Maryland School of Medicine (UMSOM), has been appointed to lead the prestigious committee of experts who review and approve all proposed research projects involving human participants for the Maryland Department of Health (MDH). She will chair the MDH Institutional Review Board (IRB) for the next four years, a position she started in July.
Wednesday, May 05, 2021
The Maryland Daily Record has named three leading faculty members at the University of Maryland School of Medicine to its 2021 listing of Maryland’s Top 100 Women. The three-- Tracy L. Bale, PhD, Professor of Pharmacology; Kimberly Lumpkins, MD, MBA, Associate Professor of Surgery; and Jill RachBeisel, MD, the Dr. Irving J. Taylor Professor and Chair of Psychiatry—were chosen for their “outstanding achievements demonstrated through professional accomplishments, community leadership and mentoring,” according to the publication.
Wednesday, February 03, 2021
Clinical and Academic Leader, Dr. Jill RachBeisel, Appointed Chair of the Department of Psychiatry at the UM School of Medicine
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that Jill RachBeisel, MD, Associate Professor of Psychiatry, has been appointed to serve as the Chair of the Department of Psychiatry, effective immediately. Dr. RachBeisel has served as the Department’s Interim Chair for the past two years and was previously Acting Chair and Vice Chair of the Department. A prominent leader at UMSOM, she has garnered tremendous support among faculty and staff for her efforts to forge partnerships among various entities in an effort to strengthen mental health services provided to patients and the community at large. Dr. RachBeisel will be named The Dr. Irving J. Taylor Endowed Professor and Chair, Department of Psychiatry, when she is invested March 18.
Thursday, February 27, 2020
Jill RachBeisel, MD, Interim Chair of the Department of Psychiatry at the University of Maryland School of Medicine (UMSOM), along with UMSOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Gloria Reeves, MD, Associate Professor of Psychiatry, has been appointed to serve as the Vice Chair for Research of the Department.
Thursday, January 16, 2020
University of Maryland School of Medicine Research Shows That Older Patients With Untreated Sleep Apnea Need Greater Medical Care
Obstructive sleep apnea (OSA) is a common and costly medical condition leading to a wide range of health risks such as cardiovascular disease, stroke, depression, diabetes and even premature death. Researchers at the University of Maryland School of Medicine (UMSOM) found that the medical costs are substantially higher among older adults who go untreated for the disorder.
Wednesday, October 16, 2019
Researchers Discover Potential Therapy to Treat Detrimental Effects of Marijuana in Pre-Adolescent Individuals Exposed to THC in Womb
As a growing number of U.S. states legalize the medicinal and recreational use of marijuana, an increasing number of American women are using cannabis before becoming pregnant and during early pregnancy often to treat morning sickness, anxiety, and lower back pain. Although emerging evidence indicates that this may have long-term consequences for their babies’ brain development, how this occurs remains unclear.
Thursday, April 04, 2019
Health and addiction treatment officials from the Caroline County Health Department, Maryland Department of Health, the Maryland Opioid Operational Command Center, and the University of Maryland School of Medicine (UMSOM) in Denton, MD., launched the Eastern Shore Mobile Care Collaborative (ESMCC), a mobile system designed to provide state-of-the-art treatment for opioid disorders for those in need on the Maryland Eastern shore.
Wednesday, March 27, 2019
UMSOM Researchers Discover a Critical Receptor Involved in the Response to Fast-Acting Antidepressants Like Ketamine
Effective treatment of clinical depression remains a major mental health issue, with roughly 30 percent of patients who do not respond to any of the available treatments. Researchers at the University of Maryland School of Medicine (UMSOM) have discovered a crucial receptor called mGlu2 that is critical to the mechanism of fast-acting antidepressants such as ketamine when used to treat depression.
Thursday, November 08, 2018
Clinical Affairs Leader and Educator Dr. David B. Schwartz Announces Retirement from UM School of Medicine
University of Maryland School of Medicine Senior Associate Dean for Clinical Affairs, Anthony Lehman, MD, along with UMSOM Dean E. Albert Reece, MD, PhD, MBA, announced today that David B. Schwartz, MD, Director of Clinical Affairs Special Programs and Clinical Professor in the Department of Obstetrics and Gynecology’s Division of Maternal Fetal Medicine, will retire at the end of year.
Tuesday, October 16, 2018
Bankole Johnson, DSc, MD, the Dr. Irving J. Taylor Professor and Chair of the Department of Psychiatry at the University of Maryland School of Medicine (UMSOM), has been named to receive the American Society of Addiction Medicine’s (ASAM) R. Brinkley Smithers Distinguished Scientist Award.
Friday, January 05, 2018
Fighting Opioid Addiction from Baltimore to Garrett County: University of Maryland School of Medicine Rises to the Challenge
The opioid epidemic has been deadly for Maryland. In 2016, more than 2000 people in the state died from overdoses; in 2017, deaths rose another 40 percent, and deaths from the powerful synthetic opioid fentanyl were up nearly 140 percent. Last year, Gov. Larry Hogan declared a state of emergency in response to the opioid epidemic, saying the state needs an “all-hands-on-deck approach.”